Newron Pharmaceuticals

Devon Energy remains inherently discounted compared to its peers despite the recent bounce, thanks to its growing production capacity and richer profit margins. Thanks to the still healthy balance sheet and rich cash flow generations, we believe that the oil/gas company remains well positioned to continue deleveraging while paying out dividends. On the other hand, readers must note that the oil/ gas sector is an inherently volatile sector, worsened by the ongoing OPEC+ output relaxation and non-OPEC+ increases.» Mehr auf seekingalpha.com

Energy stocks are proving their strength, outperforming the market despite oil price stagnation. Structural shifts, deglobalization, and inflation favor long-term upside. Shale growth is slowing, and oil companies are prioritizing cash flow over expansion. With rising costs, $70 oil is the new $50, limiting U.S. production at lower prices. Uncertainty in policy and tariffs adds pressure, but I see oil stabilizing near $90 long term. My top energy picks remain strong plays for income and capital appreciation.» Mehr auf seekingalpha.com

The S&P 500 index recently slipped over 10% from its peak and officially entered the correction territory. Although it has rebounded since, the heightened volatility amid economic and geopolitical concerns and stubborn inflation have put dividend stocks in the spotlight.» Mehr auf fool.com